Late Onset of ANCA Vasculitis as a Side Effect of Levamisole Treatment in Nephrotic Syndrome
신증후군에서 Levamisole 치료의 부작용으로 ANCA 혈관염의 늦은 발병
Case Reports
[키워드] Administered
affected
age
alterations
ANCA-vasculitis
antibody
Arthritis
autoantibody
Awareness
Bilirubin
Case report
celiac disease
children
circulating
clinical manifestation
clinical manifestations
clinician
cocaine
cocaine abuse
COVID-19 vaccine
cumulative
cytopenia
cytoplasmic
decrease
demonstrated
diagnosed
direct bilirubin
disease
dose
drug reaction
Effect
Fever
foot
hand
high fever
induce
initial
injection
joint
lack
Levamisole
liver enzyme
liver enzymes
manifestation
MPO
myeloperoxidase
nephrotic syndrome
nephrotic syndrome.
nine
Onset
positive
raise
receive
reduction in
reported
returned
second dose
secondary to
side
Side effect
Side effects
steroid
Symptom
Symptoms
syndrome
the patient
total and direct bilirubin
treated
Treatment
vaccination
Vasculitis
was measured
[DOI] 10.3390/medicina58050650 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.3390/medicina58050650 PMC 바로가기 [Article Type] Case Reports